FOXO4-DRI Peptide Potential Support for Fibrosis in Cell Cultures Based on research by Han et al., FOXO4-DRI may support cellular fibrosis by shifting the balance away from senescent, pro-fibrotic cell states and away from myofibroblast-driven matrix production
Editorial refresh Practical 2026 note for Does the VA Cover GLP This update makes Does the VA Cover GLP more specific by tying semaglutide, tirzepatide, cash-pay pricing, military, coverage, glp to the page's original clinical, cost, access, or comparison angle
Higher levels of circulating albumin may reduce the risk of PC and serve as a potential biomarker
NCT05520775: Semaglutide for Alcohol Use Disorder Status: Underway This is an early-Phase II human trial using a randomized, placebo-controlled, dose-ranging design to investigate the effects of semaglutide, a GLP-1 receptor agonist, on alcohol-related outcomes in adults with alcohol use disorder
B12 is involved in metabolism and energy production, so if a deficiency is contributing to low energy and making it hard to exercise, injections might indirectly support weight loss efforts by boosting energy